Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy D Shapiro

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Research and Practice in Thrombosis and Haemostasis|January 19, 2019
Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia BAmy D Shapiro, K John Pasi, Margareth C Ozelo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 18, 2025
Safety and Efficacy of Long-Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement TherapyAmy D Shapiro, Heather McDaniel, Robert W Decker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 30, 2019
Population-based surveillance of haemophilia and patient outcomes in Indiana using multiple data sourcesAmanda I Okolo, John Michael Soucie, Scott D Grosse, et al.
Research and Practice in Thrombosis and Haemostasis|September 18, 2023
Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demandMaría-Teresa Álvarez-Román, Amy D Shapiro, Margaret V Ragni, et al.
Patient Preference and Adherence|June 30, 2016
A validated measure of adherence to antibiotic prophylaxis in children with sickle cell diseaseNatalie A Duncan, William G Kronenberger, Kisha C Hampton, et al.
European Journal of Haematology|December 8, 2021
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disordersOmotola O Olasupo, Craig Haddix, Charles Nakar, et al.
Haematologica|February 1, 2020
An international registry of patients with plasminogen deficiency (HISTORY)Amy D Shapiro, Marzia Menegatti, Roberta Palla, et al.
Research and Practice in Thrombosis and Haemostasis|December 11, 2023
Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort studyOmotola O Olasupo, Charles Nakar, Craig Haddix, et al.
Stem Cell Research|April 12, 2017
Generation of human iPSCs from urine derived cells of a non-affected control subjectMuhammad Zeeshan Afzal, Melanie Gartz, Ekaterina A Klyachko, et al.
Stem Cell Research|December 10, 2016
Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutationMuhammad Zeeshan Afzal, Melanie Gartz, Ekaterina A Klyachko, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Research and Practice in Thrombosis and Haemostasis|January 19, 2019
Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia BAmy D Shapiro, K John Pasi, Margareth C Ozelo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 18, 2025
Safety and Efficacy of Long-Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement TherapyAmy D Shapiro, Heather McDaniel, Robert W Decker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 30, 2019
Population-based surveillance of haemophilia and patient outcomes in Indiana using multiple data sourcesAmanda I Okolo, John Michael Soucie, Scott D Grosse, et al.
Research and Practice in Thrombosis and Haemostasis|September 18, 2023
Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demandMaría-Teresa Álvarez-Román, Amy D Shapiro, Margaret V Ragni, et al.
Patient Preference and Adherence|June 30, 2016
A validated measure of adherence to antibiotic prophylaxis in children with sickle cell diseaseNatalie A Duncan, William G Kronenberger, Kisha C Hampton, et al.
European Journal of Haematology|December 8, 2021
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disordersOmotola O Olasupo, Craig Haddix, Charles Nakar, et al.
Haematologica|February 1, 2020
An international registry of patients with plasminogen deficiency (HISTORY)Amy D Shapiro, Marzia Menegatti, Roberta Palla, et al.
Research and Practice in Thrombosis and Haemostasis|December 11, 2023
Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort studyOmotola O Olasupo, Charles Nakar, Craig Haddix, et al.
Stem Cell Research|April 12, 2017
Generation of human iPSCs from urine derived cells of a non-affected control subjectMuhammad Zeeshan Afzal, Melanie Gartz, Ekaterina A Klyachko, et al.
Stem Cell Research|December 10, 2016
Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutationMuhammad Zeeshan Afzal, Melanie Gartz, Ekaterina A Klyachko, et al.
Pageof 8